Sodium alginate oligosaccharides (NaAOs) consisting of a mixture of eight oligosaccharides have previously been reported to lower blood pressure. We investigated in this study the excretion of NaAOs into the urine or feces, and attempted to elucidate the mechanism for lowering blood pressure by using isolated mesenteric arteries from the rabbit. The recovery rate of P8, which is the main component of NaAOs, was 5.2% and 58.9% over 48 hours in the urine and feces, respectively. The mechanism for lowering blood pressure appeared to be NaAOs having calcium antagonist activity, especially voltage-operated calcium channels. Our results suggest that NaAOs are substantially excreted into the feces, although some of them may be absorbed internally, exerting antagonist activity towards the calcium channels, especially voltage-operated calcium channels.
Alginate is a natural acidic polysaccharide with a molecular weight of 2.7 million and is the main component of brown algae. This polysaccharide plays an important role in keeping the seaweed flexible and the intercellular tissues strong. 1) We have developed a production method for sodium alginate oligosaccharides of less than 1,000 molecular weight by decomposing sodium alginates with alginate lyase derived from a marine bacterium. We subsequently revealed that NaAOs were composed of 8 kinds of component and determined the chemical structures of those components. 2) We then examined the physiological functions of NaAOs and have reported the antihypertensive effect in an animal study 3) and the hypotensive effects in clinical studies. 4, 5) Moreover, we have confirmed their safety from an acute toxicity test, subacute toxicity test, 6) subchronic toxicity study, and mutagenic test. However, there have been no reports on the metabolism and hypotensive mechanism of NaAOs. To investigate the metabolism in the present study, we attempted to confirm the absorption and excretion of NaAOs after their oral administration. In addition, to elucidate the hypotensive mechanism, we examined the relaxant response and relative contribution of NaAOs components by using mesenteric arteries isolated from the rabbit.
Materials and Methods
Drugs. Sodium pentobarbital and papaverine hydrochloride were purchased from Dainippon Sumitomo Pharma Co. (Osaka, Japan). All other reagents used were of special grade from Wako Pure Chemical Corp. (Osaka, Japan) or Junsei Chemical Co. (Tokyo, Japan).
Preparation of NaAOs. NaAOs were prepared according to the method previously reported.
2) Alginate lyase was prepared from a broth of Pseudoalteromonas sp. strain No. 1786 that had been cultivated with 1% (w/v) sodium alginate (320-380 cps, 1% solution at y To whom correspondence should be addressed. Fax: +81-29-864-6719; E-mail: t-chaki@maruha.co.jp Abbreviations: NaAOs, sodium alginate oligosaccharides;
; DEAE, diethylaminoethyl; HPLC, high-performance liquid chromatography; ACE, angiotensin I-converting enzyme; KHS, Krebs-Henzeleit solution; ring samples, rabbit mesenteric artery ring samples; MVC, micro-vessel chamber; HKCaFS, high-K þ -and-Ca 2þ -free solution; VOCCs, voltage-operated calcium channels; RACCs, receptor-activated calcium channels; LGCCs, ligand-gated non-specific cation channels; NE, norepinephrine; IP 3 , inositol 1,4,5-triphosphate 20 C, Kimica Corp., Kimitsu, Japan) as the carbon source. The NaAOs powder obtained was diluted with distilled water and subjected to high-performance liquid chromatography (HPLC) in a diethylaminoethyl (DEAE) anion-exchange column. The analytical conditions and elution profile of each oligosaccharide by HPLC are shown in Fig. 1 (P1, P2, P3, P4, P5, P6, P7, and P8 in order of elution). Mass spectrometry and nuclear magnetic resonance techniques were employed to determine the structure of each oligosaccharide (Table 1 ).
7)
Preparation of each peak. An aqueous solution containing 5% NaAOs was prepared and fractionated in a DEAE column (COSMOGEL DEAE glass, 20 mm Â 100 mm, Nacalai Tesque, Kyoto, Japan) to produce 8 peaks. Subsequent purification of each peak was performed with a small-scale electrodialyzer to remove inorganic salts (G1 Micro Acilyzer, Astom Corp., Kawasaki, Japan). The white lyophilized powder was used for the subsequent examination. The purity of each peak was confirmed to be over 96% by the analytical DEAE HPLC method shown in Fig. 1 .
Determination of the recovery rate from urine and feces. Twelve male Wistar rats were purchased from Charles River Laboratories Japan (Yokohama, Japan) at 8 weeks of age. One week after their arrival, the rats were randomly divided into 2 groups, the test group and control group (6 animals in each group), and individually housed in stainless steel cages in a room with a controlled temperature (23 AE 1 C), humidity (50 AE 10%), and lighting (alternating 12-hour cycles of light from 7:00 to 19:00 and dark from 19:00 to 7:00). The rats were freely supplied with commercial feed (MF, 
Oriental Yeast Co., Tokyo, Japan) and water (Tsukuba city tap water) during the entire period. Each rat in the test group was administered with 1.0 g of P8 dissolved in 1.5 ml of distilled water (3.0 g/kg), while that in the control group was given only 1.5 ml of distilled water. Thereafter, the urine and feces were collected every 24 hours on 3 occasions in 72 hours. The urine was diluted 1:10 with distilled water, filtered (0.45 mm, DISMIC-3CP cellulose acetate, Advantec Toyo Kaisha, Tokyo, Japan), and subjected to DEAE HPLC. The feces were lyophilized and weighed, before being suspended in a phosphate buffer (pH 2.4). This suspension was sonicated (2 times for 1 min each) and extracted over 12 hours at room temperature under rotary shaking (170 rpm). After this extraction, the supernatant was centrifuged at 1;000 Â g for 20 min and then at 10;000 Â g for 20 min. The resulting supernatant was diluted with distilled water, filtered (0.45 mm, DISMIC-3CP cellulose acetate, Advantec Toyo Kaisha), and subjected to DEAE HPLC, while the precipitate derived from centrifugation was dissolved again in a phosphate buffer (pH 2.4), sonicated (2 times for 1 min each), and then extracted over 12 hours at room temperature under rotary shaking (170 rpm). This extraction procedure was conducted 4 times, and each supernatant was subjected to DEAE HPLC. The recovery rate was evaluated by the HPLC area ratio.
Assay of angiotensin I-converting enzyme inhibitory activity. NaAOs and Captopril were used as samples diluted with distilled water to the prescribed concentration. The inhibitory activity of the angiotensin Iconverting enzyme from bovine lung (ACE, Wako Pure Chemical Corp., Osaka, Japan) was measured by a slightly modified method. 8, 9) A 50-ml amount of the sample was incubated with 100 ml of a substrate (100 mM K 2 HPO 4 (pH 8.3), 300 mM NaCl, and 2.5 mM Hip-HisLeu) for 5 min at 37 C. After this preincubation, the reaction was initiated by adding 50 ml of the 0.05 U/ml ACE solution (100 mM K 2 HPO 4 (pH 8.3)) and incubating for 30 min at 37 C. The reaction was stopped by adding 200 ml of 3% metaphosphoric acid, and the reaction solution filtered (0.45 mm, DISMIC-3CP cellulose acetate, Advantec Toyo Kaisha). The amount of liberated hippuric acid was determined by HPLC with the Shiseido SI-1 system, the ACE inhibitory activity being expressed as the IC 50 value, the concentration of the sample which exhibited 50% ACE inhibition under the assay conditions.
Relaxant response of the isolated mesenteric artery. Albino male rabbits weighing about 2 kg were anesthetized with sodium pentobarbital (30 mg/kg, i.v.) and then exsanguinated from the carotid artery. The mesenteric artery was quickly removed and cut into 3.0-mm lengths (ring sample) after removing all tissues surrounding the artery (approximately 1 mm in diameter). The ring sample was horizontally mounted on two Lshaped tungsten wires (50 mm in diameter) that were fixed in a 2-ml micro-vessel chamber (MVC, Fig. 2 ) in a Krebs-Henzeleit nutrient solution (KHS) with the following composition (mM): NaCl, 112; KCl, 4.5; CaCl 2 , 2.5; MgCl 2 , 1.2; NaHCO 3 , 26; KH 2 PO 4 , 1.2; glucose, 11.1. This KHS solution was maintained at a constant 36. 5 C and bubbled with mixed gas of 95% O 2 and 5% CO 2 .
After adjusting the resting tension of the ring samples to 0.3 g and keeping them at equilibrium for over 1 hour, the examination was started. We first added 20 ml of 3 M KCl to confirm the reactivity of the ring sample, and then MVC was washed out by the KHS solution. The ring sample was depolarized by a high-K þ -and-Ca 2þ -free solution (HKCaFS) with the following composition (mM): NaCl, 0; KCl, 112; CaCl 2 , 0; MgCl 2 , 1.2; NaHCO 3 , 26; KH 2 PO 4 , 1.2; glucose, 11.1; EGTA, 1.0. The ring sample then contracted by 1 mM CaCl 2 at the final concentration. After confirming the plateau and stability of the contractive reaction, we cumulatively added each peak of NaAOs from 0.1 mM to 5.0 mM. At the end of each experiment, 0.1 mM papaverine was added to attain the maximum relaxation. The isotonic tension was measured by means of an isometric distortional pressure sensor (UL-2G, Minebea Co., Nagano, Japan) connected to a polygraph. The response of each peak is expressed as a percentage of the maximum relaxation which was generated by the addition of 0.1 mM papaverine. We subsequently calculated the gradient and investigated the relaxation strength ratio of each peak, with P8 being designated as 1.0. Figure 3 shows an example of the peak behavior under this experimental condition. The relaxant response for each peak was measured in 8 ring samples. All experimental procedures in this study met the guidelines of the Animal Care and Use Committee of Kinki University School of Medicine.
Relative contribution of each peak. In order to calculate the relative contribution of each peak to calcium antagonism, the weight ratio for an equal HPLC area of each peak was compared, the corrective
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This method is described as the relaxant response of an isolated mesenteric artery in the Materials and Methods section. coefficient being described against P8 as 1.0. Finally, the relative contribution of each component was determined from the peak area rate, relaxation strength ratio, and corrective coefficient.
Statistical analysis. Each result is expressed as raw data, or as the mean AE standard deviation (S.D.). Significant differences were assessed by a Scheffe post hoc analysis, differences being considered to be statistically significant at P < 0:05. This analysis was performed with Stat View Ver. 5.0 software.
Results
Determination of the recovery rate from urine and feces Table 2 shows the recovery rate of P8 from the urine and feces. The recovery rate from urine was 4:7 AE 2:1% within 24 hours, and 0:5 AE 0:5% from 24 to 48 hours, a total of 5.2% being recovered on average over two days with the test group. The recovery rate from feces was 54:4 AE 7:6% during 24 hours and 4:6 AE 2:0% from 24 to 48 hours, a total of 64.1% being recovered on average over two days with the test group. No further P8 could be detected in either the urine or feces from 48 to 72 hours with the test group. No presence of P8 could be detected with the control group at any time examined. Figure 4 shows the ACE activity induced by Captopril (Fig. 4A) and NaAOs (Fig. 4B) . Captopril, the ACE inhibitor, was found to have an IC 50 value of 3:0 Â 10 À7 (M). On the other hand, NaAOs did not show any ACE inhibitory activity, even at 2:0 Â 10 À2 (M). Table 3 shows the relaxant response rate of each peak at each concentration. These results indicate that the relaxing effect of each peak increased with increasing concentration. Since constant linearity was observed for each peak, we calculated the gradient to determine the relaxation strength ratio, with P8 being designated as 1.0. As shown in Table 4 , P4 and P6 had high values, the ratios being 1.41-and 1.37-fold, respectively. In contrast, P1 and P5 had low values of 0.93-and 0.81-fold, respectively. However, there were no significant differences among peaks in this experiment.
ACE inhibitory activity
Relaxant response of an isolated mesenteric artery
Relative contribution of each peak
The weight ratio for an equal HPLC area of each peak was compared. The weight ratios for disaccharide, trisaccharide, and tetrasaccharide against P8 as 1.0 were 0.50, 0.75 and 1.02, respectively, these results showing good correlation (R 2 ¼ 0:9995) between the sensitivity and number of double bonds at the non-reducing terminals. We defined the corrective coefficients for disaccharide, trisaccharide, and tetrasaccharide as 0.5, 0.75, and 1.0 for the HPLC peak area rate. As shown in The ring sample was contracted by 1 mM CaCl 2 at the final concentration. After confirming the plateau and stability of the contractive reaction, each peak sample was cumulatively added from 0.1 mM to 5.0 mM. At the end of each experiment, 0.1 mM papaverine was added to attain the maximum relaxation. 
Discussion
We investigated in the present study the excretion of P8, the main peak of NaAOs, into the urine and/or feces, and evaluated that about 60% of P8 was excreted into the feces and 5% into the urine. These results are similar to our preliminary one that the total excretion rate of NaAOs (n ¼ 3) into the feces was 56.9% during 48 hours (data not shown). It has been reported that approximately 90% of low-molecular-weight sodium alginate (50;000 AE 10;000) was excreted into the feces during the first 24 hours after it had been orally administered at a dose of 2.0 g/kg to 7-week-old male The ACE inhibitory activity was measured by the slightly modified method of Cushman and Cheung, and Horiuchi et al. This method is described in detail as the assay of angiotensin I-converting enzyme inhibitory activity in the Materials and Methods section. The analytical conditions were as follows: column, CAPCELL PAK C 18 ACR, 4:6 mm Â 250 mm (Shiseido Co., Tokyo, Japan); monitoring wavelength, 226 nm; column temperature, 40 C; mobile phase, 10 mM K 2 HPO 4 (pH 2.8)/100% acetonitrile = 80:20; flow rate, 1.0 ml/min; analytical time, 8 min. Wistar rats. 10) Likewise, 72.7%-79.3% of alginic acid and its salts were excreted into the feces within 72 hours after administering 90.4 mg/kg to 4-week-old male Wistar rats (n ¼ 3).
11) Humphreys and Triffitt have investigated the excretion and absorption of sodium alginate labelled with 14 C by using 10-week-old rats, and reported that 85.6-91.4% or more was excreted into the feces and 0.11-0.16% into the urine, with 0.002-0.007% being recovered from the plasma after 17 hours of feeding a diet containing 10% alginate (n ¼ 1{2).
12) It appears from these results that the excretion of NaAOs may exhibit similar behavior to that of low-molecularweight sodium alginate or alginate. In regard to this behavior, Hidaka et al. have reported that no utilization of sodium alginate was apparent in 72 human-derived strains. 13) We therefore investigated the utilization of NaAOs by using 120 strains of bacteria derived from the human intestine, and confirmed that it was similarly negative (data not shown). These results suggest that it would be difficult for NaAOs to be utilized by intestinal bacteria, resulting in the excretion of NaAOs into the feces at a level of approximately 60%.
In respect of the urinary excretion, more NaAOs amount was detected in comparison with sodium alginate, suggesting that a part of NaAOs may have been internally absorbed and then excreted into the urine. We investigated the presence of P8 in the serum 1 hour and 2 hours after an oral administration (3.0 g/kg) to 8-week-old male Wistar rats, and confirmed P8 at 65 mg/ml after 1 hour and at 34 mg/ml after 2 hours, whereas no P8 could be detected in the control group (n ¼ 2, data not published). This result could support the idea that a small quantity of P8 was internally absorbed. This is the first report to our knowledge that oligosaccharides such as P8 may be internally absorbed. However, further investigation using another method will be necessary to confirm this notion.
The mechanism for lowering the blood pressure and the relative contribution of each peak to the hypotensive effect were next examined. It is well known that such peptides as lactotripeptides, 14) peptides derived from sardines, 15) and peptides found in Nori seaweed 16) assist in lowering the blood pressure. Many functional foods containing these peptides have been approved as Foods for Specified Health Uses. It has been documented that the hypotensive mechanism of these peptides was mainly due to ACE inhibition. 17) We therefore measured the ACE inhibitory activity of NaAOs, but we could not detect it at all, even at 2:0 Â 10 À2 (M). These results indicate that the mechanism for lowering blood pressure could involve in an alternative pathway, not an ACE inhibitor like a peptide.
We subsequently examined the calcium antagonism of NaAOs to elucidate the mechanism for lowering blood pressure. An elevation of the calcium concentration in a cell is necessary for smooth muscle cells to contract. This elevation may be induced by an influx of calcium across the plasma membrane and/or a release of calcium from the endoplasmic reticulum. 18) Regarding the influx of calcium through the plasma membrane, it has been reported that there were three main pathways by which extracellular calcium can travel: 19) these are voltage-operated calcium channels (VOCCs) opened by depolarization, receptor-activated calcium channels (RACCs) activated by binding agonists to receptors, and ligand-gated non-specific cation channels (LGCCs).
The suppression of contraction was dose-dependently observed in this study after depolarization by HKCaFS ( Table 3 ), suggesting that the hypotensive mechanism could involve antagonism for VOCCs. On the other hand, it is known that agonists, for example norepinephrine (NE), binding receptors lead to the activation of phospholipase C which in turn generates inositol 1,4,5-triphosphate (IP 3 ) and diacylglycerol. 20) IP 3 mediates the discharge of calcium from intracellular stores. The depletion of intracellular calcium stores signals the activation of capacitative calcium entry, occurring through store-operated calcium channels. 21) We investigated the effect of NaAOs on the contractile response of NE by using MVC. However, 1 mM NaAOs had no effect on NE contraction (an NE concentration from 1:0 Â 10 À8 to 1:0 Â 10 À5 (M)), suggesting that the hypotensive mechanism of NaAOs was not related to RACCs. Taking all these results together, antagonism for VOCCs may be responsible, at least in part, for the hypotensive action of NaAOs. However, the potency of each peak was less than one hundredth of that of diltiazem, the calcium antagonist, which has been reported to provide 100% relaxant concentration at 1:0 Â 10 À5 (M). 22) In respect of the potency among peaks, there was no significant difference, indicating that the structure or molecular size of NaAOs may be not important for the demonstration of calcium antagonism. Accordingly, P8 was the most important peak among NaAOs because it constituted 30.06% of the whole HPLC area.
In conclusion, the results of this present study indicate that approximately 60% of NaAOs were excreted into the feces, like the case of alginates, after an oral administration, but that part of them may be internally absorbed, exerting antagonist activity toward calcium channels, especially VOCCs. These findings provide a new insight to clarify, at least in part, the metabolism and mechanism by which NaAOs lower blood pressure.
